Anti-tumour activity of two novel compounds in cisplatin-resistant testicular germ cell cancer

BACKGROUND: Resistance to cisplatin-based chemotherapy is associated with poor prognosis in testicular germ cell cancer, emphasising the need for new therapeutic approaches. In this respect, the therapeutic concept of anti-angiogenesis is of particular interest. In a previous study, we presented two...

Descripción completa

Detalles Bibliográficos
Autores principales: Nitzsche, B, Gloesenkamp, C, Schrader, M, Hoffmann, B, Zengerling, F, Balabanov, S, Honecker, F, Höpfner, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504942/
https://www.ncbi.nlm.nih.gov/pubmed/23169338
http://dx.doi.org/10.1038/bjc.2012.481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3504942/
https://www.ncbi.nlm.nih.gov/pubmed/23169338
http://dx.doi.org/10.1038/bjc.2012.481

Ejemplares similares